JP2022528783A5 - - Google Patents

Info

Publication number
JP2022528783A5
JP2022528783A5 JP2021560711A JP2021560711A JP2022528783A5 JP 2022528783 A5 JP2022528783 A5 JP 2022528783A5 JP 2021560711 A JP2021560711 A JP 2021560711A JP 2021560711 A JP2021560711 A JP 2021560711A JP 2022528783 A5 JP2022528783 A5 JP 2022528783A5
Authority
JP
Japan
Application number
JP2021560711A
Other languages
Japanese (ja)
Other versions
JP2022528783A (ja
JP7602483B2 (ja
JPWO2020208202A5 (https=
Filing date
Publication date
Priority claimed from EP19168685.6A external-priority patent/EP3721871A1/de
Application filed filed Critical
Publication of JP2022528783A publication Critical patent/JP2022528783A/ja
Publication of JP2022528783A5 publication Critical patent/JP2022528783A5/ja
Publication of JPWO2020208202A5 publication Critical patent/JPWO2020208202A5/ja
Application granted granted Critical
Publication of JP7602483B2 publication Critical patent/JP7602483B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021560711A 2019-04-11 2020-04-09 有効成分顆粒の連続製造のための方法 Active JP7602483B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19168685.6 2019-04-11
EP19168685.6A EP3721871A1 (de) 2019-04-11 2019-04-11 Verfahren zur kontinuierlichen herstellung eines wirkstoffgranulats
PCT/EP2020/060278 WO2020208202A1 (de) 2019-04-11 2020-04-09 Verfahren zur kontinuierlichen herstellung eines wirkstoffgranulats

Publications (4)

Publication Number Publication Date
JP2022528783A JP2022528783A (ja) 2022-06-15
JP2022528783A5 true JP2022528783A5 (https=) 2023-04-14
JPWO2020208202A5 JPWO2020208202A5 (https=) 2023-04-14
JP7602483B2 JP7602483B2 (ja) 2024-12-18

Family

ID=66105207

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021560711A Active JP7602483B2 (ja) 2019-04-11 2020-04-09 有効成分顆粒の連続製造のための方法

Country Status (13)

Country Link
US (1) US12551443B2 (https=)
EP (2) EP3721871A1 (https=)
JP (1) JP7602483B2 (https=)
CN (2) CN118649138A (https=)
AU (1) AU2020271280B2 (https=)
BR (1) BR112021020282A2 (https=)
CA (1) CA3144742A1 (https=)
DK (1) DK3952844T3 (https=)
ES (1) ES3053040T3 (https=)
IL (1) IL287121B1 (https=)
PL (1) PL3952844T3 (https=)
PT (1) PT3952844T (https=)
WO (1) WO2020208202A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102024107710A1 (de) * 2024-03-18 2025-09-18 Glatt Gesellschaft Mit Beschränkter Haftung Verfahren zur Herstellung von Tabletten
DE102024107712A1 (de) * 2024-03-18 2025-09-18 Glatt Gesellschaft Mit Beschränkter Haftung Vorrichtung zur Herstellung von Tabletten

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0739201T3 (da) 1994-01-14 2000-05-01 Ethypharm Lab Prod Ethiques Mikrogranuler af 5-nitro-imidazolderivater
DE19514187C1 (de) * 1995-04-21 1996-05-15 Degussa Verfahren und Vorrichtung zur Herstellung von Granulaten durch Wirbelschicht-Sprühgranulation
PT1117729E (pt) * 1998-07-21 2004-01-30 Vantico Ag Granulados escoaveis
US6117451A (en) 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets
DE10004939C1 (de) 2000-02-05 2001-08-23 Lothar Moerl Steuerbare Gasanströmeinrichtung für Strahlschichtapparate
NZ526720A (en) * 2000-12-28 2007-11-30 Altus Pharmaceuticals Inc Crystallisation of whole antibodies or fragments thereof, on a large scale and a process allowing an alternative route for delivery of therapeutic antibodies
US6667054B2 (en) 2001-12-05 2003-12-23 Bernard Charles Sherman Metformin hydrochloride tablets
KR100592512B1 (ko) * 2002-11-22 2006-07-03 서울약품공업(주) 탐술로신 또는 약제학적으로 허용되는 이의 염을활성성분으로 하는 서방성 배뇨장애 치료제
DE10322062A1 (de) 2003-05-15 2004-12-02 Glatt Ingenieurtechnik Gmbh Verfahren und Vorrichtung zum Aufbringen von Flüssigkeiten in eine Feststoffströmung eines Strahlschichtapparates
ES2374191T3 (es) 2003-06-11 2012-02-14 Glatt Ingenieurtechnik Gmbh Procedimiento de preparación de granulados de enzimas y granulados de enzimas así obtenidos.
DE102005037630A1 (de) * 2005-08-09 2007-02-15 Glatt Gmbh Verfahren zur Herstellung von Teilchen aus pharmazeutischen Substanzen, Teilchen aus pharmazeutischen Substanzen sowie deren Verwendung
DE102007012105A1 (de) * 2007-03-13 2008-09-18 Add Advanced Drug Delivery Technologies Ltd. Pellets enthaltend pharmazeutische Substanz, Verfahren zu deren Herstellung und deren Verwendung
WO2010066385A1 (de) 2008-12-08 2010-06-17 Ratiopharm Gmbh Kompaktiertes moxifloxacin
WO2010106555A2 (en) 2009-03-17 2010-09-23 Shantilal, Doshi, Bimalkumar Directly compressible pre-granulated cellulose ether polymer and process for preparing the same
JP5922310B2 (ja) * 2013-07-25 2016-05-24 株式会社三和化学研究所 医薬製剤
WO2018034627A1 (en) * 2016-08-18 2018-02-22 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Pharmaceutical composition of antidiabetic tablet
EP3721870A1 (de) * 2019-04-11 2020-10-14 ADD Advanced Drug Delivery Technologies, Ltd. Verfahren zur kontinuierlichen herstellung eines wirkstoffgranulats

Similar Documents

Publication Publication Date Title
JP2022528783A5 (https=)
CN306031923S (https=)
CN306043307S (https=)
CN305536845S (https=)
CN305536144S (https=)
CN305536130S (https=)
CN305534692S (https=)
CN305534448S (https=)
CN305532932S (https=)
CN305557530S (https=)
CN305531443S (https=)
CN305530626S (https=)
CN305557002S (https=)
CN305528856S (https=)
CN305528834S (https=)
CN305527181S (https=)
CN305554193S (https=)
CN306315049S (https=)
CN306307139S (https=)
CN306293486S (https=)
CN305552947S (https=)
CN306292020S (https=)
CN306260768S (https=)
CN306260388S (https=)
CN306258858S (https=)